Indeed, proteasome inhibitors block Fanconi anemia and homologous recombination pathways, rendering MM cells addict on BER initiated by PARP1/2-mediated Poly(ADP-ribosyl)ation of proteins[38]. This evidence concerns the gene PARP1 and Fanconi anemia.